Company / Working Capital
Bruker Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$933.3M
FY2025
5-year range
$771.9M / $1.5B
FY2021-FY2025
Trend
+20.9%
vs FY2024
Sector context
#41 of 165
Health Care
What the data says
Bruker's working capital of $933M is higher than 75% of companies in the Health Care sector (FY2025). Working Capital returned to growth in FY2025 after 3 years of decline, reaching $933M.
Based on SEC 10-K filings.
$933M in FY2025 with a 5-year CAGR of -3.8%. Top quartile in the Health Care sector.
Declined from $962M to $933M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -8.0%
- 5-Year CAGR
- -3.8%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 165This company $933.3M Sector average $836.2M
▼
+11.6% above sector average
Key checks
Key Insights
- 5-year CAGR of -3.8%, indicating a declining trend.
- In FY2025, working capital increased 20.9% year-over-year.
- Ranks #41 out of 165 companies in the Health Care sector.
- Peak working capital was recorded in FY2021.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $933.3M | +20.9% |
| FY2024 | $771.9M | -19.8% |
| FY2023 | $962.1M | -19.8% |
| FY2022 | $1.2B | -21.8% |
| FY2021 | $1.5B | +35.3% |
| FY2020 | $1.1B | -1.5% |
| FY2019 | $1.2B | +63.2% |
| FY2018 | $705.0M | -15.5% |
| FY2017 | $834.3M | +11.1% |
| FY2016 | $751.2M | +11.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026